How much are patients willing to pay to avoid postoperative muscle pain associated with succinylcholine?

Abstract

Study Objective To determine how much money patients are willing to pay to avoid postoperative muscle pains associated with succinylcholine. Design Observational study with survey instrument. Setting University-affiliated metropolitan hospital. Patients Eighty-eight adult patients, 43 men and 45 women, who were scheduled to undergo surgery with general anesthesia and who completed a preoperative questionnaire (median age range, 41-50 y; median income, US$45,000-60,000). Interventions and Measurements Patients completed a computerized, interactive questionnaire preoperatively. They were asked about demographics and previous experiences with muscle pain and postoperative myalgia. With the use of the willingness-to-pay model, the value that they would be willing to pay for a hypothetical muscle relaxant that avoided postoperative myalgia was determined. Main Results Eighty-nine percent of patients considered avoiding postoperative myalgia as important. Patients were willing to pay a median (interquartile range) of $33 ($19-$50) out of pocket for a muscle relaxant that was not associated with postoperative myalgia, a figure that increased to $40 if the insurance company paid for the drug ( P < 0.0001). Willingness to pay was influenced by patients' income but not by prior experience with postoperative myalgia. Conclusion Patients consider avoidance of postoperative myalgia important and are willing to pay $33 out of pocket for a muscle relaxant that is not associated with this side effect.